Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
Yoel Angel, Avishay Spitzer, Oryan Henig, et al.
JAMA (2021) Vol. 325, Iss. 24, pp. 2457-2457
Open Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Qiao Liu, Chenyuan Qin, Min Liu, et al.
Infectious Diseases of Poverty (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 311
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
Po Ying Chia, Sean Wei Xiang Ong, Calvin J. Chiew, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 4, pp. 612.e1-612.e7
Open Access | Times Cited: 296
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study
Hannah Chung, Siyi He, Sharifa Nasreen, et al.
BMJ (2021), pp. n1943-n1943
Open Access | Times Cited: 287
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Karin Bok, Sandra Sitar, Barney S. Graham, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1636-1651
Open Access | Times Cited: 230
Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis
Victoria Rotshild, Bruria Hirsh Raccah, Ian Miskin, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 217
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022
Nana Wu, Keven Joyal‐Desmarais, Paula Aver Bretanha Ribeiro, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 5, pp. 439-452
Open Access | Times Cited: 187
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel
Tamara Pilishvili, Ryan Gierke, Katherine E. Fleming-Dutra, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 25
Open Access | Times Cited: 169
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study
Po Ying Chia, Sean Wei Xiang Ong, Calvin J. Chiew, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 166
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 151
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021
Thomas Harder, Judith Koch, Sabine Vygen-Bonnet, et al.
Eurosurveillance (2021) Vol. 26, Iss. 28
Open Access | Times Cited: 116
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)
Simone Cesaro, Per Ljungman, Małgorzata Mikulska, et al.
Leukemia (2022) Vol. 36, Iss. 6, pp. 1467-1480
Open Access | Times Cited: 105
COVID-19 vaccine – Long term immune decline and breakthrough infections
Johad Khoury, Ronza Najjar‐Debbiny, Ayman Hanna, et al.
Vaccine (2021) Vol. 39, Iss. 48, pp. 6984-6989
Open Access | Times Cited: 101
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel
Avishay Spitzer, Yoel Angel, Or Marudi, et al.
JAMA (2022) Vol. 327, Iss. 4, pp. 341-341
Open Access | Times Cited: 94
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
Marit J. van Gils, A. H. Ayesha Lavell, Karlijn van der Straten, et al.
PLoS Medicine (2022) Vol. 19, Iss. 5, pp. e1003991-e1003991
Open Access | Times Cited: 93
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 81
Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies
Chia Siang Kow, Syed Shahzad Hasan
Inflammopharmacology (2021) Vol. 29, Iss. 4, pp. 1075-1090
Open Access | Times Cited: 77
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers
Francesca Rovida, Irene Cassaniti, Stefania Paolucci, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 65
Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis
Scott Sibbel, Katherine L. Mckeon, Jiacong Luo, et al.
Journal of the American Society of Nephrology (2021) Vol. 33, Iss. 1, pp. 49-57
Open Access | Times Cited: 57
Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents
Nina Koerber, Alina Priller, Sarah Yazici, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Prevention of host-to-host transmission by SARS-CoV-2 vaccines
Darius Mostaghimi, Caroline N Valdez, Haleigh Tianna Larson, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. e52-e58
Open Access | Times Cited: 57
Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans
Yinong Young‐Xu, Caroline Korves, Jeff Roberts, et al.
JAMA Network Open (2021) Vol. 4, Iss. 10, pp. e2128391-e2128391
Open Access | Times Cited: 56
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 43
COVID‐19 and plasma cells: Is there long‐lived protection?*
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top